Workflow
HilleVax(HLVX)
icon
Search documents
HilleVax (HLVX) Investor Presentation - Slideshow
2022-12-02 14:28
CORPORATE PRESENTATION NOVEMBER 2022 Disclaimer We caution you that this presentation contains forward-looking statements of HilleVax, Inc. ("HilleVax," "we," "us" or similar terms). All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, research and development plans, the anticipated timing, costs, design and conduct of our planned and potential clinical trials and pr ...
HilleVax(HLVX) - 2022 Q3 - Quarterly Report
2022-11-10 21:31
FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR WASHINGTON, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-41365 HILLEVAX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...
HilleVax(HLVX) - 2022 Q2 - Quarterly Report
2022-08-10 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-41365 HILLEVAX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 85-05 ...
HilleVax(HLVX) - 2022 Q1 - Quarterly Report
2022-06-08 20:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41365 HILLEVAX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 85-0545060 (State or other jurisdiction of incorporation or organization) 75 S ...